ATE100717T1 - Intralaesionale behandlung von basalzellenkarzinoma mittels rekombinanten humanen alpha-interferons. - Google Patents

Intralaesionale behandlung von basalzellenkarzinoma mittels rekombinanten humanen alpha-interferons.

Info

Publication number
ATE100717T1
ATE100717T1 AT87304642T AT87304642T ATE100717T1 AT E100717 T1 ATE100717 T1 AT E100717T1 AT 87304642 T AT87304642 T AT 87304642T AT 87304642 T AT87304642 T AT 87304642T AT E100717 T1 ATE100717 T1 AT E100717T1
Authority
AT
Austria
Prior art keywords
cell carcinoma
recombinant human
basal cell
intraaesional
treatment
Prior art date
Application number
AT87304642T
Other languages
English (en)
Inventor
Daniel Jay Tanner
Edwin Arnold Peets
Kenneth Albert Smiles
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE100717T1 publication Critical patent/ATE100717T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT87304642T 1986-05-27 1987-05-26 Intralaesionale behandlung von basalzellenkarzinoma mittels rekombinanten humanen alpha-interferons. ATE100717T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86664486A 1986-05-27 1986-05-27
EP87304642A EP0248583B1 (de) 1986-05-27 1987-05-26 Intraläsionale Behandlung von Basalzellenkarzinoma mittels rekombinanten humanen alpha-Interferons

Publications (1)

Publication Number Publication Date
ATE100717T1 true ATE100717T1 (de) 1994-02-15

Family

ID=25348060

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87304642T ATE100717T1 (de) 1986-05-27 1987-05-26 Intralaesionale behandlung von basalzellenkarzinoma mittels rekombinanten humanen alpha-interferons.

Country Status (13)

Country Link
EP (1) EP0248583B1 (de)
JP (1) JPS62289526A (de)
KR (1) KR870010871A (de)
AT (1) ATE100717T1 (de)
AU (1) AU601741B2 (de)
CA (1) CA1295243C (de)
DE (1) DE3788899T2 (de)
DK (1) DK264787A (de)
ES (1) ES2061496T3 (de)
IE (1) IE62318B1 (de)
IL (1) IL82654A0 (de)
PH (1) PH26198A (de)
ZA (1) ZA873743B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028422A (en) * 1986-05-27 1991-07-02 Schering Corporation Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
EP0278715A3 (de) * 1987-02-09 1989-03-08 Schering Corporation Verwendung von menschlichem Gamma-Interferon für die Behandlung von Basalzell-Karzinomen
US5256410A (en) * 1988-12-01 1993-10-26 Schering Corporation Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon
EP0446279A1 (de) * 1988-12-01 1991-09-18 Schering Corporation Intralesionsbehandlung von schuppenartigem zellkarzinom mit rekombinantem, humanem alpha-interferon
IL100415A0 (en) * 1990-12-21 1992-09-06 Schering Corp Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases
EP3600379B1 (de) * 2017-03-31 2022-12-21 Accanis Biotech F&E GmbH & Co KG Vorbeugung und behandlung von nichtmelanom-hautkrebs (nmsc)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0077063B1 (de) * 1981-10-13 1988-03-16 Exovir, Inc. Interferon enthaltende Zusammensetzungen und die Anwendung dieser Zusammensetzungen in der Behandlung von Herpesinfektionen, prämalignen Hautverletzungen, Hautmalignitäten und Psoriasis
US5098703A (en) * 1982-01-15 1992-03-24 Cetus Corporation Interferon-alpha 76
AU1153083A (en) * 1982-01-15 1983-07-28 Cetus Corporation Interferon-alpha 54
EP0098864A1 (de) * 1982-01-15 1984-01-25 Cetus Corporation Interferon-alpha 74
US4822605A (en) * 1986-02-18 1989-04-18 Exovir, Inc. Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like
US4853218A (en) * 1987-02-24 1989-08-01 Schering Corporation Zinc-protamine-alpha interferon complex

Also Published As

Publication number Publication date
EP0248583B1 (de) 1994-01-26
PH26198A (en) 1992-03-18
JPS62289526A (ja) 1987-12-16
AU601741B2 (en) 1990-09-20
DE3788899T2 (de) 1994-05-05
KR870010871A (ko) 1987-12-18
IE871358L (en) 1987-11-27
DE3788899D1 (de) 1994-03-10
DK264787D0 (da) 1987-05-25
IL82654A0 (en) 1987-11-30
CA1295243C (en) 1992-02-04
ZA873743B (en) 1987-11-25
EP0248583A3 (en) 1989-10-18
AU7336687A (en) 1987-12-03
EP0248583A2 (de) 1987-12-09
ES2061496T3 (es) 1994-12-16
DK264787A (da) 1987-11-28
IE62318B1 (en) 1995-01-25

Similar Documents

Publication Publication Date Title
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
IL87621A0 (en) Conjugates of cytokines with immunoglobulins,their preparation and pharmaceutical compositions containing them
NO852673L (no) Tumor-nekrosefaktor.
IT8619055A0 (it) Composizioni farmaceutiche comprendenti peptidi del gruppo colecistochinina-cerulina per il trattamento terapeutico degli statidi shock e dell'insufficienza respiratoria e cardiocircolatoria.
IT1183181B (it) Derivati del 3-metil-imidazo(4,5-c)pirazolo con attivita' terapeutica e procedimento per la loropreparazione
DE3788899D1 (de) Intraläsionale Behandlung von Basalzellenkarzinoma mittels rekombinanten humanen alpha-Interferons.
ATE174798T1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
ATE74272T1 (de) Pharmazeutischer stoff fuer die behandlung von myelogener leukaemie.
DK0643973T3 (da) Anvendelse af humant interferon-beta til fremstilling af farmaceutiske præparater til behandling af kronisk myeloid leukæmi
DE3773295D1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
DE69001686D1 (de) Behandlung von leukozytstoerungen mit gm-csf.
ES2115582T3 (es) Preparacion y aplicaciones de interferon-gamma.
DE3861494D1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
DK103891A (da) Intralaesional behandling af pladeepitelcarcinoma med rekombinant human alfainterferon
OA08768A (fr) Traitement du virus su SIDA par l'interféron alpha humain recombinant.
DE3750248D1 (de) Zubereitung und Behandlung der Haut mit Human-Leukocyten-Interferon.
DE69104619D1 (de) Verwendungsmethoden von humanem Gammainterferon 4-134.
ATE26267T1 (de) Pyrimidin-derivate, ausgestattet mit antiviraler wirkung.
KR920014480A (ko) 기흉 치료용 제약 조성물을 제조하기 위한 인간 인터류킨 2의 활성을 갖는 폴리펩티드의 용도
KR900012628A (ko) 감마 인터페론의 유효량을 함유하는 복강내 투여용 난소암 치료제
ATE54941T1 (de) Cystein verminderte muteine von biologisch aktiven menschlichen tnf-proteinen.
KR880001300A (ko) 리트로바이러스 감염의 예방 및 치료를 위한 방법 및 조성물

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee